Xuhui Yang

758 total citations
33 papers, 535 citations indexed

About

Xuhui Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xuhui Yang has authored 33 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Xuhui Yang's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Xuhui Yang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Xuhui Yang collaborates with scholars based in China, Czechia and Tunisia. Xuhui Yang's co-authors include Andy Peng Xiang, Xiao Xie, Xinbing Yu, Bruce T. Lahn, Mingsong Wang, Chenxi Li, Zhifeng Yan, Cheng Xu, Nan Du and Zihao Liu and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and RSC Advances.

In The Last Decade

Xuhui Yang

32 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuhui Yang China 16 256 141 135 65 57 33 535
Aleksandra Głogowska Canada 14 244 1.0× 89 0.6× 156 1.2× 53 0.8× 56 1.0× 25 512
Anna Paczulla Germany 8 297 1.2× 152 1.1× 96 0.7× 42 0.6× 33 0.6× 13 550
Pei Liang China 14 343 1.3× 122 0.9× 146 1.1× 59 0.9× 77 1.4× 20 597
Qiong Zhu China 14 320 1.3× 109 0.8× 97 0.7× 36 0.6× 49 0.9× 30 550
Qi Niu China 16 302 1.2× 100 0.7× 69 0.5× 46 0.7× 39 0.7× 57 654
Yi‐Wen Chang Taiwan 12 326 1.3× 215 1.5× 150 1.1× 36 0.6× 39 0.7× 23 558
Ron Batash Israel 8 181 0.7× 93 0.7× 93 0.7× 79 1.2× 40 0.7× 13 453
Shuting Yang United States 15 373 1.5× 106 0.8× 95 0.7× 40 0.6× 38 0.7× 40 605
Hyunkoo Kang South Korea 17 317 1.2× 99 0.7× 212 1.6× 95 1.5× 42 0.7× 41 736
Zixiang Wu China 10 291 1.1× 73 0.5× 90 0.7× 48 0.7× 21 0.4× 18 490

Countries citing papers authored by Xuhui Yang

Since Specialization
Citations

This map shows the geographic impact of Xuhui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuhui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuhui Yang more than expected).

Fields of papers citing papers by Xuhui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuhui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuhui Yang. The network helps show where Xuhui Yang may publish in the future.

Co-authorship network of co-authors of Xuhui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuhui Yang. A scholar is included among the top collaborators of Xuhui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuhui Yang. Xuhui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chenxi, et al.. (2024). Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer. Translational Oncology. 51. 102208–102208.
2.
He, Jing, et al.. (2023). D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC. Oncogene. 42(47). 3503–3513. 4 indexed citations
3.
Xu, Xiaojie, et al.. (2023). Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer. Thoracic Cancer. 14(11). 983–991. 2 indexed citations
4.
Li, Chenxi, Xuhui Yang, Hui Li, et al.. (2023). Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer. European journal of medical research. 28(1). 360–360. 10 indexed citations
5.
Wang, Chunyu, Xuhui Yang, Lingling Li, et al.. (2023). Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases. Frontiers in Oncology. 13. 1110949–1110949. 1 indexed citations
6.
Li, Lingling, Tingting Liu, Qingyan Liu, et al.. (2022). Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer. Frontiers in Pharmacology. 13. 967559–967559. 20 indexed citations
7.
Chen, Miao, Xuhui Yang, Chaojie Liu, et al.. (2021). Comparative efficacy and cognitive function of magnetic seizure therapy vs. electroconvulsive therapy for major depressive disorder: a systematic review and meta-analysis. Translational Psychiatry. 11(1). 437–437. 22 indexed citations
8.
Hu, Rui, et al.. (2021). LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA. Journal of Cancer. 12(21). 6393–6400. 5 indexed citations
9.
Liu, Zihao, Xudong Han, Chenxi Li, et al.. (2020). Identifying Cancer-Related lncRNAs Based on a Convolutional Neural Network. Frontiers in Cell and Developmental Biology. 8. 637–637. 4 indexed citations
10.
Yang, Xuhui, et al.. (2020). Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression. Cancer Biotherapy and Radiopharmaceuticals. 35(2). 120–128. 14 indexed citations
11.
Yang, Xuhui, et al.. (2020). Reverse “L” surgical approach for the management of giant tumors of the cervicothoracic junction. Journal of Thoracic Disease. 12(8). 3995–4001. 3 indexed citations
12.
13.
Yang, Xuhui, Hui Zhao, Jing Yang, et al.. (2019). MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect. Biochemical and Biophysical Research Communications. 515(1). 85–91. 39 indexed citations
14.
Yang, Xuhui, et al.. (2019). Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress. Thoracic Cancer. 10(4). 676–685. 25 indexed citations
15.
Yang, Xuhui, Tian Xia, Jie Zhang, et al.. (2017). RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G1/S arrest via Akt-GSK3β-Rb pathway. Current Medical Science. 37(6). 895–903. 1 indexed citations
16.
He, Wei, et al.. (2011). Ginsenoside-Rg1 mediates microenvironment-dependent endothelial differentiation of human mesenchymal stem cellsin vitro. Journal of Asian Natural Products Research. 13(1). 1–11. 13 indexed citations
17.
Xu, Caixia, Peiqiang Su, Yingjun Wang, et al.. (2010). A novel biomimetic composite scaffold hybridized with mesenchymal stem cells in repair of rat bone defects models. Journal of Biomedical Materials Research Part A. 95A(2). 495–503. 23 indexed citations
18.
Chen, Zhenguang, Tao Wang, Honghe Luo, et al.. (2010). Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients. Human Pathology. 41(5). 737–744. 25 indexed citations
19.
20.
Xu, Caixia, Yingjun Wang, YU Xin-bing, et al.. (2008). Evaluation of human mesenchymal stem cells response to biomimetic bioglass‐collagen‐hyaluronic acid‐phosphatidylserine composite scaffolds for bone tissue engineering. Journal of Biomedical Materials Research Part A. 88A(1). 264–273. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandra Głogowska Breakdown of academic impact, for papers by Anna Paczulla Breakdown of academic impact, for papers by Pei Liang Breakdown of academic impact, for papers by Qiong Zhu Breakdown of academic impact, for papers by Qi Niu Breakdown of academic impact, for papers by Yi‐Wen Chang Breakdown of academic impact, for papers by Ron Batash Breakdown of academic impact, for papers by Shuting Yang Breakdown of academic impact, for papers by Hyunkoo Kang Breakdown of academic impact, for papers by Zixiang Wu
Rankless by CCL
2026